Dr. Seeds MOTS-c protocol explained: typical dosing, timing, cycle length, and safety notes for this research peptide, plus how it stacks up to others.
The Dr. Seeds MOTS-c protocol is a structured dosing schedule for MOTS-c, a mitochondrial-derived peptide sold for research use only. Most versions of the protocol call for roughly 5 to 10 mg per week, split into two or three subcutaneous injections, usually taken in the morning and typically cycled for four to eight weeks followed by a break. No regulatory agency has approved MOTS-c for human use, so the protocol reflects clinical and community convention rather than an established medical standard.
What Is the Dr. Seeds MOTS-c Protocol?
Dr. William Seeds is an orthopedic surgeon who has published widely read peptide therapy protocols, and his MOTS-c entry is one of several versions circulating online. The core idea is straightforward: deliver a small amount of MOTS-c on a repeating schedule so that exposure stays relatively stable across the week.
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. In laboratory and animal research it has been linked to AMPK activation, glucose handling, and metabolic stress responses. Human data remains very limited.
Versions of the same schedule circulate under other names, including the Jay Campbell MOTS-c approach and the Vigorous Steve MOTS-c breakdown, and they generally land in a similar dose range.
Typical MOTS-c Dosing, Frequency, and Timing
Most people who work from a mots c dosage chart keep the weekly total between 5 mg and 10 mg. Smaller, more frequent injections are more common than a single large dose because they tend to be easier to tolerate at the injection site.
| Protocol Element | Commonly Reported Range | Notes |
|---|---|---|
| Weekly dose | 5–10 mg | Split across the week rather than given at once |
| Injection frequency | 2–3 times per week | About 2.5–5 mg per injection |
| Timing | Morning, often fasted | Chosen to match natural metabolic rhythms |
| Cycle length | 4–8 weeks on | Usually followed by 2–4 weeks off |
| Route | Subcutaneous | Abdomen or thigh, with rotated sites |
Because no human trial has established a dose, these numbers are estimates. Many people search for a Dr. Seeds MOTS-c protocol PDF, but the published book remains the most reliable source; screenshots shared on social media often leave out the caveats.
Subcutaneous Injection Basics
- Use a fresh needle each time and rotate sites to reduce irritation.
- Reconstitute only if you fully understand the math and sterility requirements.
- Keep reconstituted peptide refrigerated and protected from light.
Why Timing and Cycle Length Matter
MOTS-c is studied as a metabolic signaling peptide, and its natural levels rise with exercise and fasting. That is why many protocols place injections in the morning and pair them with training days. Cycling is a precaution rather than a proven requirement, since long-term human exposure data does not exist.
What MOTS-c Is Actually Studied For
Reported areas of interest include insulin sensitivity, fat oxidation, exercise capacity, and age-related metabolic decline. Almost all of the mechanistic work has been done in cells or rodents, not in people.
- Metabolic regulation: AMPK pathway activation is the most cited mechanism.
- Exercise response: Animal studies suggest changes in endurance markers.
- Aging research: Mitochondrial-derived peptides decline with age, which drives interest in replacement.
None of this amounts to proof of benefit in humans. MOTS-c is not a treatment for diabetes, obesity, or any other medical condition.
How MOTS-c Compares to Other Research Peptides
The aod 9604 vs mots-c comparison comes up constantly, but the two compounds are studied for different endpoints — fat metabolism versus cellular energy sensing. The lipo c vs mots c debate usually centers on whether you want a lipotropic injection blend or a mitochondrial signaling peptide.
| Compound | Primary Research Focus | Typical Weekly Dose |
|---|---|---|
| MOTS-c | Metabolic signaling, AMPK | 5–10 mg |
| SS-31 (elamipretide) | Mitochondrial membrane protection | Varies; often 5–20 mg |
| AOD-9604 | Fat metabolism | 300–600 mcg |
| Lipo-C / MIC blends | Lipotropic support | 1–2 mL per session |
| SLU-PP-332 | Exercise mimetic (not a peptide) | Research only |
Because both compounds act on mitochondria, some researchers look at ss-31 and mots-c as a logical pairing. The slu-pp-332 vs mots-c question is newer, since SLU-PP-332 is a small-molecule exercise mimetic rather than a peptide. Anyone comparing aod 9604 dosage protocol figures with MOTS-c dosing should note that the two are measured in completely different units.
Safety, Sourcing, and Legal Status
MOTS-c is not FDA-approved for human use in the United States. It is sold as a research chemical, which means purity, sterility, and actual content are not guaranteed by any regulator.
- Reported side effects are mostly mild and include injection site reactions, headache, and fatigue.
- Long-term safety data in humans does not exist.
- Unregulated suppliers have been shown to ship underdosed or mislabeled vials.
Talk with a licensed healthcare professional before using any research peptide, especially if you take prescription medication, are pregnant or breastfeeding, or manage a chronic condition. Baseline bloodwork and follow-up labs are a reasonable precaution.
Questions to Ask Before Starting
- Is a licensed clinician supervising this, and do they know my full medication list?
- Can the supplier provide a certificate of analysis from an independent lab?
- What am I measuring, and on what schedule, to know whether anything changed?
Frequently Asked Questions
What is the Dr. Seeds MOTS-c protocol dose?
Published versions of the protocol generally list about 5 to 10 mg of MOTS-c per week, split into two or three subcutaneous injections, often given in the morning. Cycles typically run four to eight weeks followed by a break. No human clinical trial has established an official dose, so these figures are estimates rather than medical guidance.
Is MOTS-c FDA-approved for human use?
No. MOTS-c is not FDA-approved for human use in the United States and is legally sold only as a research chemical, not as a drug or dietary supplement. That means purity, dosing accuracy, and sterility are not verified by any regulator. Buying it for injection carries sourcing and safety risks that a clinician cannot fully mitigate.
Can MOTS-c be stacked with other peptides?
Community protocols sometimes pair MOTS-c with other mitochondria-targeted compounds, but no human study has tested those combinations for safety or effectiveness. Stacking also makes it harder to tell which compound caused a side effect. Anyone considering a stack should discuss it with a healthcare professional first.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.